Aug 2026· International Journal of Infectious Diseases· pp.
109075
· 0 citations· 24 references
Medicine
TL;DR
The SVD outbreak in Uganda during January-April, 2025 had a low CFR and a low Rt, possibly due to early detection and swift identification, quarantine, and close monitoring of contacts.
Abstract
Background
On January 30, 2025, the Ministry of Health, Uganda (MoH), announced an outbreak of Sudan ebolavirus disease (SVD). We describe the epidemiological characteristics and transmission dynamics of the SVD outbreak in Uganda during January-April, 2025.
Methods
SVD cases were identified using MoH case definitions and were classified as confirmed if positive on RT-qPCR or probable if an SVD-related death was reported with epidemiological linkage but without laboratory confirmation. Cases were identified through contact tracing, community and health facility alerts, and active search. Data were collected using a standard SVD case investigation form, including demographics, exposures and outcome. The effective reproductive number (Rt) was estimated using the EpiEstim package in R.
Results
Fourteen cases were identified between January 30 and April 25, 2025: 12 (86%) were confirmed and 2 (14%) were probable; and 5 (36%) were health workers. The mean (range) age was 27 (0-50) years. Four cases died, a case fatality rate (CFR) of 29% (4/14). Most exposures were household (9[64%]) followed by healthcare-associated exposures (3[21%]). The index case was a health worker who died of a febrile illness 11 days after symptom onset, and postmortem samples returned positive for SUDV on the same day. A total of 534 contacts were monitored; of these, 454 (85%) were quarantined. Ten cases were known contacts; no secondary transmission occurred among these cases. The estimated Rt (interquartile range) was 1.1 (0.83-1.35).
Conclusion
The outbreak had a low CFR and a low Rt, possibly due to early detection and swift identification, quarantine, and close monitoring of contacts.
Background. West Nile Virus (WNV) infection represents a public health challenge due to its seasonal pattern and the risk of neuroinvasive disease, particularly among older adults and vulnerable individuals. Monitoring the geographical distribution and viral circulation is essential for prevention. In Italy, WNV, epide...
R. Furnari, F. Fiorito, G. Giorgianni et al.· Journal of Biological Resear...· 0 citations
Mpox is a re-emerging zoonotic disease caused by a double-stranded DNA virus of the genus Orthopoxvirus. Since 2017, Nigeria has witnessed a resurgence of Mpox, with outbreaks of increasing magnitude. This study analyzed surveillance data from the Surveillance Outbreak Response and Management System (SORMAS) spanning S...
C. Azuka, Kwarbai Aaron Maitala, A. Akyala et al.· International journal of pub...· 0 citations
West Nile fever (WNF) is a zoonotic arboviral disease caused by West Nile virus (WNV), maintained primarily in an enzootic cycle involving birds and mosquitoes, particularly species of the genus Culex. Although evidence of viral circulation has previously been documented in Brazil, human disease remains infrequently re...
D. Tolentino, Eliseu Miranda de Assis· Pandemics· 0 citations
The study supports Nigeria’s Cholera Control Programme in refining hygiene strategies, regulating street food safety and targeting high-risk groups, such as young children, in targeting high-risk groups.
Aisha A. Abba, C. Ameh, A. Sadauki et al.· Journal of Public Health in...· 0 citations
Cases positive only for NS1 were the most frequent, indicating early infection, followed by cases positive for both NS1 and IgM, followed by cases positive for both NS1 and IgM.
Rabita Hijam, Pratibha Huidrom, Ranjeeta Sougaijam· Journal of Advances in Biolo...· 0 citations
OBJECTIVE
To describe the epidemiological characteristics of imported hepatitis A cases reported to the National Epidemiological Surveillance Network (RENAVE) in Spain from 2015 to 2023.
METHOD
A descriptive analysis was conducted of case characteristics, including sex, age and country of travel. The study period was...
María Guerrero-Vadillo, À. Domínguez, N. Torner et al.· Gaceta Sanitaria· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.